Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1579, doi. 10.1007/s13300-020-00850-w
- By:
- Publication type:
- Article
Works matching IS 18696953 AND DT 2020 AND VI 11 AND IP 7
Results: 14
1
2
Assessing Diabetes Distress and Sleep Quality in Young Adults with Type 1 Diabetes Using FreeStyle Libre: A Prospective Cohort Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1551, doi. 10.1007/s13300-020-00849-3
- By:
- Publication type:
- Article
3
COVID-19: Impact of and on Diabetes.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1429, doi. 10.1007/s13300-020-00847-5
- By:
- Publication type:
- Article
4
Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1563, doi. 10.1007/s13300-020-00846-6
- By:
- Publication type:
- Article
5
Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1591, doi. 10.1007/s13300-020-00845-7
- By:
- Publication type:
- Article
6
Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends.
- Published in:
- 2020
- By:
- Publication type:
- Letter
7
Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1527, doi. 10.1007/s13300-020-00841-x
- By:
- Publication type:
- Article
8
Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1537, doi. 10.1007/s13300-020-00840-y
- By:
- Publication type:
- Article
9
Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1437, doi. 10.1007/s13300-020-00839-5
- By:
- Publication type:
- Article
10
Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1513, doi. 10.1007/s13300-020-00838-6
- By:
- Publication type:
- Article
11
Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1497, doi. 10.1007/s13300-020-00837-7
- By:
- Publication type:
- Article
12
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1481, doi. 10.1007/s13300-020-00836-8
- By:
- Publication type:
- Article
13
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
14
Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 7, p. 1467, doi. 10.1007/s13300-020-00815-z
- By:
- Publication type:
- Article